| Epigenome-wide association studies: current knowledge, strategies and recommendations MP Campagna, A Xavier, J Lechner-Scott, V Maltby, RJ Scott, ... Clinical epigenetics 13, 1-24, 2021 | 83 | 2021 |
| The pharmacogenetics of rituximab: Potential implications for anti-CD20 therapies in multiple sclerosis M Zhong, A Van Der Walt, MP Campagna, J Stankovich, H Butzkueven, ... Neurotherapeutics 17 (4), 1768-1784, 2020 | 17 | 2020 |
| Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity VG Jokubaitis, MP Campagna, O Ibrahim, J Stankovich, P Kleinova, ... Brain 146 (6), 2316-2331, 2023 | 16 | 2023 |
| Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity MP Campagna, A Xavier, RA Lea, J Stankovich, VE Maltby, H Butzkueven, ... Clinical epigenetics 14 (1), 194, 2022 | 11 | 2022 |
| Patient preferences for time and location of infusible therapies in multiple sclerosis and neuroimmunologic disorders L Rath, MP Campagna, J Stankovich, J Ellis, V Jokubaitis, D McCarthy, ... International Journal of MS Care 23 (3), 114-118, 2021 | 5 | 2021 |
| Evaluation of cell-specific epigenetic age acceleration in people with multiple sclerosis V Maltby, A Xavier, E Ewing, MP Campagna, S Sampangi, RJ Scott, ... Neurology 101 (7), e679-e689, 2023 | 3 | 2023 |
| DNA methylation signatures of multiple sclerosis occur independently of known genetic risk and are primarily attributed to B cells and monocytes A Xavier, VE Maltby, E Ewing, MP Campagna, SM Burnard, JN Tegner, ... International Journal of Molecular Sciences 24 (16), 12576, 2023 | 3 | 2023 |
| Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis MP Campagna, A Xavier, J Stankovich, VE Maltby, M Slee, WZ Yeh, ... Clinical epigenetics 15 (1), 20, 2023 | 3 | 2023 |
| Birth history is associated with whole-blood and T-cell methylation patterns in relapse onset multiple sclerosis MP Campagna, A Xavier, J Stankovich, V Maltby, M Slee, T Kilpatrick, ... medRxiv, 2022.03. 24.22272917, 2022 | 2 | 2022 |
| Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes MP Campagna, J Lechner-Scott, VE Maltby, RA Lea, H Butzkueven, ... Autoimmunity reviews, 103388, 2023 | 1 | 2023 |
| B cells exhibit marked epigenetic age acceleration in multiple sclerosis V Maltby, A Xavier, E Ewing, MP Campagna, R Scott, H Butzkueven, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 85-85, 2022 | 1 | 2022 |
| The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial WZ Yeh, M Gresle, R Lea, B Taylor, RM Lucas, AL Ponsonby, D Mason, ... Clinical Immunology 262, 110183, 2024 | | 2024 |
| No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry MP Campagna, EK Havrdova, D Horakova, G Izquierdo, F Matesanz, ... Multiple Sclerosis Journal, 13524585241240406, 2024 | | 2024 |
| Pharmacogenomic prediction of ocrelizumab outcomes in multiple sclerosis M Zhong, MP Campagna, S Sampangi, A Kermode, M Pedrini, ... MULTIPLE SCLEROSIS JOURNAL 29, 973-974, 2023 | | 2023 |
| An epigenetic signature is associated with Multiple Sclerosis independently of known genetic risk and is a more accurate classifier A Xavier, V Maltby, E Ewing, MP Campagna, S Burnard, J Tegner, M Slee, ... MULTIPLE SCLEROSIS JOURNAL 29, 589-589, 2023 | | 2023 |
| Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis A Xavier, MP Campagna, VE Maltby, T Kilpatrick, BV Taylor, ... Frontiers in immunology 14, 1162796, 2023 | | 2023 |
| DNA methylation signatures of Multiple Sclerosis occur independently of genetic risk and are primarily attributed to B cells and monocytes A Xavier, VE Maltby, E Ewing, MP Campagna, SM Burnard, JN Tegner, ... | | 2023 |
| Impact of pregnancy history on whole-blood methylation in women with relapse-onset multiple sclerosis MP Campagna, A Xavier, J Lechner-Scott, H Butzkueven, RJ Scott, R Lea, ... MULTIPLE SCLEROSIS JOURNAL 28 (4_ SUPPL), 3-3, 2022 | | 2022 |
| Whole-blood methylation as a prognostic biomarker for multiple sclerosis MP Campagna, A Xavier, J Lechner-Scott, H Butzkueven, RJ Scott, R Lea, ... MULTIPLE SCLEROSIS JOURNAL 28 (4_ SUPPL), 2-2, 2022 | | 2022 |
| Functional epigenetic networks are associated with multiple sclerosis A Xavier, V Maltby, E Ewing, MP Campagna, RJ Scott, H Butzkueven, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 502-503, 2022 | | 2022 |
